These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5494594)

  • 21. Insulin receptor on monocytes from patients with acromegaly and fasting hyperglycemia.
    Muggeo M; Saviolakis GA; Businaro V; Valerio A; Moghetti P; Crepaldi G
    J Clin Endocrinol Metab; 1983 Apr; 56(4):733-8. PubMed ID: 6339536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatomedin on insulin-dependent diabetes mellitus.
    Cohen MP; Jasti K; Rye DL
    J Clin Endocrinol Metab; 1977 Aug; 45(2):236-9. PubMed ID: 885989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of a day-long blood sugar picture in the care of diabetics].
    Neuwirth G; Csepei M
    Orv Hetil; 1984 Apr; 125(18):1075-7. PubMed ID: 6371659
    [No Abstract]   [Full Text] [Related]  

  • 25. Fasting hyperglycemia in type I diabetes mellitus.
    Mozersky RP; Bahl VK; Patel H; Patel N; Palushock S; Yamakawa H; Mook W; Basuray R; Velez-Giraldo JR
    J Am Osteopath Assoc; 1993 Jul; 93(7):769-74. PubMed ID: 8365924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between serum free fatty acids and blood sugar in non-obese and obese diabetics.
    Reitsma WD
    Acta Med Scand; 1967 Sep; 182(3):353-61. PubMed ID: 6058364
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal by insulin treatment of abnormal growth hormone pattern in newly diagnosed diabetes mellitus.
    Corrall RJ; Hunter WM; Campbell IW; Harrower AD; Duncan LJ; Clarke BF
    Acta Endocrinol (Copenh); 1974 Sep; 77(1):115-21. PubMed ID: 4408350
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of muscular exercise on plasma level of growth hormone in diabetics with and without retinopathy.
    Passa P; Gauville C; Canivet J
    Lancet; 1974 Jul; 2(7872):72-4. PubMed ID: 4136822
    [No Abstract]   [Full Text] [Related]  

  • 29. [Growth hormone level in the blood serum after fasting in diabetes mellitus in relation to the degree of compensation, the presence of obesity and retinopathy].
    Avenirova ZA; Alekeseeva GG; Stepanova NA
    Probl Endokrinol (Mosk); 1973; 19(3):3-8. PubMed ID: 4724060
    [No Abstract]   [Full Text] [Related]  

  • 30. Portable continuous blood glucose analyzer.
    Hakanson H
    Methods Enzymol; 1988; 137():319-26. PubMed ID: 3287093
    [No Abstract]   [Full Text] [Related]  

  • 31. Multi-hormonal disturbances in insulin-treated diabetes.
    Danowski TS; Fisher ER; Kozak W
    Mater Med Pol; 1978; 10(4):303-6. PubMed ID: 755135
    [No Abstract]   [Full Text] [Related]  

  • 32. New blood sugar control methods for older diabetics.
    Drexler AJ; Robertson C
    Geriatrics; 1983 Jun; 38(6):118-25. PubMed ID: 6343190
    [No Abstract]   [Full Text] [Related]  

  • 33. Insulin-induced posthypoglycemic hyperglycemia as a cause of "brittle" diabetes. Clinical clues and therapeutic implications.
    Bloom ME; Mintz DH; Field JB
    Am J Med; 1969 Dec; 47(6):891-903. PubMed ID: 5362868
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal and metabolic studies of the action of fenfluramine in normal man, obesity, acromegaly and diabetes mellitus.
    Sulaiman WR; Johnson RH; Rennie MJ
    Postgrad Med J; 1975; 51 Suppl 1():125-31. PubMed ID: 1219669
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus.
    Sönksen PH; Srivastava MC; Tompkins CV; Nabarro JD
    Lancet; 1972 Jul; 2(7769):155-9. PubMed ID: 4114062
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics.
    Gerich JE; Lorenzi M; Schneider V; Kwan CW; Karam JH; Guillemin R; Forsham PH
    Diabetes; 1974 Nov; 23(11):876-80. PubMed ID: 4430415
    [No Abstract]   [Full Text] [Related]  

  • 38. Diurnal change of plasma insulin in diabetics with sulfonylurea treatment.
    Toyota T
    Tohoku J Exp Med; 1969 Aug; 98(4):345-56. PubMed ID: 5346206
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood glucose, serum immunoreactive insulin and growth hormone responses to intravenous infusion of an aminoacids mixture in healthy subjects and diabetics.
    Samal KC; Dash RJ; Sinha MK; Rastogi GK
    J Assoc Physicians India; 1977 Mar; 25(3):175-80. PubMed ID: 914746
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.